Aignostics
Berlin, Germany · Artificial Intelligence, Biotechnology, Health Care · 117 employees
Aignostics is an artificial intelligence (AI) company that transforms complex multimodal pathology data into valuable insights. By leveraging proprietary multimodal clinical data and rigorous scientific methods, Aignostics develops innovative products and services for precision medicine. The company collaborates with biopharmaceutical partners to support drug discovery and development. Established
Funding history
- Series series b — $34.0M — Oct 2024
Recent signals
- Oct 15, 2025: Launched Aignostics has launched Atlas H&E-TME, an AI-powered application for tumor microenvironment profiling aimed at biopharma researchers.
- Jan 13, 2025: Launched Aignostics Launches New Pathology Foundation Model in Collaboration with Mayo Clinic for Enhanced Performance in Healthcare.
- Oct 29, 2024: Raised $34.0M in Series series b
See plans & pricing → Track Aignostics’s funding, hiring, and signals — with verified contacts — on Fundz.